This Diagnostic Testing Company Down 60% – Time to Buy?

Despite witnessing double-digit revenue growth in the last reported quarter Natera Inc. (NTRA) stock has plunged nearly 60% year-to-date. So, let’s evaluate if it is worth buying the stock now. Read on. shutterstock.com – StockNews Natera Inc. (NTRA) is a world pioneer in cell-free DNA testing, focusing on cancer, women’s health, and organ health. It…

Should Lemonade Be in Your Portfolio This Summer?

Although insurance companies benefit from rising interest rates, Lemonade (LMND) failed to surpass the consensus EPS estimate in the last reported quarter. Analysts expect its EPS to remain negative in fiscal 2022 and 2023. So, will LMND be able to turn around in this rising interest rate environment? Read on to find our view…. shutterstock.com…

3 Benefits to Increasing Your Capacity

Opinions expressed by Entrepreneur contributors are their own. Before we jump into increasing our capacity, let’s first define what capacity is. Capacity is the amount that something can contain and the amount that something can produce. When entrepreneurs feel burnt out or overwhelmed, it’s typically because they feel they can’t contain anymore, or they feel…

NVDA Still Looks Expensive After Falling 50%

Although NVIDIA (NVDA) beat consensus EPS and revenue estimates in the last reported quarter, the stock has fallen more than 50% from its 52-week highs. Despite the heavy correction, the semiconductor giant trades at a premium to its peers. So, is it wise to buy the stock now? Read more to find out…. shutterstock.com –…

VRTX is the Growth Stock of the Week

Inflation may be peaking, while growth is certainly slowing. These conditions are tough for most stocks, but pharmaceuticals are an exception. One of the top companies in the space is Vertex Pharmaceuticals (VRTX). Read on to find out why it’s our growth stock of the week. shutterstock.com – StockNews 2022 has been a brutal year…

Stocks to Fall MUCH FURTHER this Bear Market Cycle

Spoiler alert…the bear market is not over. Unfortunately history shows that the S&P 500 (SPY) has much further to fall to squeeze out excess valuation. That is just a natural part of the bear market process that is properly explained in this timely market commentary. More importantly, this commentary provides a strategy on how to…